Evidence map›Paper›PMID 28366046›Full record

ArticleRedox report : communications in free radical research2017

Sodium arsenite-induced cardiovascular and renal dysfunction in rat via oxidative stress and protein kinase B (Akt/PKB) signaling pathway.

Ademola Adetokunbo Oyagbemi, Temidayo Olutayo Omobowale, Ebunoluwa Racheal Asenuga, Grace Onyeche Ochigbo, Abiola Olumuyiwa Adejumobi, Adeolu Alex Adedapo, Momoh Audu Yakubu

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The role of arsenic in obesity and diabetes.Journal of cellular physiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ademola Adetokunbo Oyagbemia Department of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine , University of Ibadan , Nigeria.ORCID http://orcid.org/0000-0002-8996-8610
Temidayo Olutayo Omobowaleb Department of Veterinary Medicine, Faculty of Veterinary Medicine , University of Ibadan , Nigeria.ORCID http://orcid.org/0000-0002-9486-2861
Ebunoluwa Racheal Asenugac Department of Veterinary Medicine, Faculty of Veterinary Medicine , University of Benin , Nigeria.
Grace Onyeche Ochigboa Department of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine , University of Ibadan , Nigeria.
Abiola Olumuyiwa Adejumobib Department of Veterinary Medicine, Faculty of Veterinary Medicine , University of Ibadan , Nigeria.
Adeolu Alex Adedapoa Department of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine , University of Ibadan , Nigeria.
Momoh Audu Yakubud Department of Environmental and Interdisciplinary Sciences , COSET, Texas Southern University , Houston , TX , USA.ORCID http://orcid.org/0000-0002-6072-2473
University of Ibadan · NGTexas Southern University · USUniversity of Benin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesArsenic is a ubiquitous element that is widely distributed in the environment to which man and animals are exposed. Cardiovascular disease is one of the aftermaths of chronic arsenic exposure-related morbidity and mortality. This study sought to investigate the possibility of reversal from arsenic-induced cardio-renal toxicity following exposure and subsequent withdrawal. The study also seeks to understand the mechanism of action of this reversal.

methodsRats were orally exposed to sodium arsenite at 10, 20 and 40 mg/kg daily for 4 weeks followed by 4 weeks of withdrawal.

resultsExposure to arsenic caused a significant increase in malondialdehyde, H

Indexed as

AnimalsAntioxidantsArsenitesImmunohistochemistryKidneyOxidative StressProto-Oncogene Proteins c-aktRatsSignal TransductionSodium CompoundsAntioxidantsArsenitesProto-Oncogene Proteins c-aktsodium arseniteSodium CompoundsArsenic acidcardiotoxicitynephrotoxicityoxidative stressprotein kinase B

Identifiers

PMID28366046
PMCPMC8900624
OpenAlexW2604189752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.